Table3_Evaluating the Causal Effects of TIMP-3 on Ischaemic Stroke and Intracerebral Haemorrhage: A Mendelian Randomization Study.XLSX
Aim: Since tissue inhibitors of matrix metalloproteinase 3 (TIMP-3) was reported to be a potential risk factor of atherosclerosis, aneurysm, hypertension, and post-ischaemic neuronal injury, it may also be a candidate risk factor of stress. Therefore, this study was designed to explore the causal role of TIMP-3 in the risk of ischaemic stroke (IS) and intracerebral haemorrhage (ICH), which are the two main causes of stress via this Mendelian Randomisation (MR) study.
Methods: The summarised data of TIMP-3 level in circulation was acquired from the Cooperative Health Research in the Region of Augsburg public database and the outcome of IS and ICH was obtained from genome-wide association studies conducted by MEGASTROKE and the International Stroke Genetics Consortium, respectively. Five statistical methods including inverse-variance weighting, weighted-median analysis, MR-Egger regression, MR Pleiotropy RESidual Sum and Outlier test, and MR-Robust Adjusted Profile Score were applied to evaluate the causal role of TIMP-3 in the occurrence of IS and ICH. Inverse-variance weighting was applied for assessing causality. Furthermore, heterogeneity and pleiotropic tests were utilised to confirm the reliability of this study.
Results: We found that TIMP-3 could be a positively causal relationship with the incidence of IS (OR = 1.026, 95% CI: 1.007–1.046, p = 0.0067), especially for the occurrence of small vessel stroke (SVS; OR = 1.045, 95% CI: 1.016–1.076, p = 0.0024). However, the causal effects of TIMP-3 on another IS subtype cardioembolic stroke (CES; OR = 1.049, 95% CI: 1.006–1.094, p = 0.024), large artery stroke (LAS; OR = 1.0027, 95% CI: 0.9755–1.0306, p = 0.849) and ICH (OR = 0.9900, 95% CI: 0.9403–1.0423, p = 0.701), as well as ICH subtypes were not observed after Bonferroni corrections (p = 0.00714).
Conclusion: Our results revealed that high levels of circulating TIMP-3 causally increased the risk of developing IS and SVS, but not CES, LAS, ICH, and all ICH subtypes. Further investigation is required to elucidate the underlying mechanism.
History
References
- https://doi.org//10.5853/jos.2016.00864
- https://doi.org//10.1093/cvr/cvt067
- https://doi.org//10.1093/ije/dyv080
- https://doi.org//10.1002/gepi.21965
- https://doi.org//10.1093/ije/dyw220
- https://doi.org//10.1016/j.bbamcr.2010.01.003
- https://doi.org//10.1007/s10654-015-0011-z
- https://doi.org//10.1007/s00415-019-09511-w
- https://doi.org//10.7554/eLife.17536
- https://doi.org//10.1038/s41598-020-69008-9
- https://doi.org//10.2174/138945013804998990
- https://doi.org//10.1084/jem.20092366
- https://doi.org//10.1007/s11886-016-0804-z
- https://doi.org//10.1161/CIRCRESAHA.116.309321
- https://doi.org//10.1001/jama.2017.17219
- https://doi.org//10.1016/S1474-4422%2819%2930034-1
- https://doi.org//10.1016/S1474-4422%2821%2900252-0
- https://doi.org//10.1161/CIRCRESAHA.119.315380
- https://doi.org//10.1016/j.prp.2016.11.008
- https://doi.org//10.1002/sim.6522
- https://doi.org//10.1074/jbc.M100121200
- https://doi.org//10.1093/hmg/ddy163
- https://doi.org//10.1291/hypres.30.563
- https://doi.org//10.1167/iovs.07-1444
- https://doi.org//10.1111/ene.14878
- https://doi.org//10.1016/j.biopha.2017.07.053
- https://doi.org//10.3109/00207454.2013.872102
- https://doi.org//10.12997/jla.2019.8.2.67
- https://doi.org//10.1016/j.brainresbull.2018.11.006
- https://doi.org//10.1016/j.neulet.2019.134399
- https://doi.org//10.1161/STROKEAHA.119.028484
- https://doi.org//10.1001/jamaneurol.2020.1512
- https://doi.org//10.1038/s41588-018-0058-3
- https://doi.org//10.1002/gepi.22207
- https://doi.org//10.1097/HJH.0b013e3283649b33
- https://doi.org//10.1038/nm846
- https://doi.org//10.1093/bioinformatics/btw373
- https://doi.org//10.1038/ncomms14357
- https://doi.org//10.3389/fendo.2020.00621
- https://doi.org//10.1371/journal.pone.0103839
- https://doi.org//10.1152/ajpheart.00780.2016
- https://doi.org//10.1038/s41588-018-0099-7
- https://doi.org//10.1161/STROKEAHA.120.029606
- https://doi.org//10.1097/01.WCB.0000040943.89393.c1
- https://doi.org//10.1016/j.ajhg.2014.02.012
- https://doi.org//10.1126/scisignal.2002689
- https://doi.org//10.1214/19-aos1866
- https://doi.org//10.1007/s40471-017-0128-6
Usage metrics
Read the peer-reviewed publication
Categories
- Gene and Molecular Therapy
- Gene Expression (incl. Microarray and other genome-wide approaches)
- Genetics
- Genetically Modified Animals
- Livestock Cloning
- Developmental Genetics (incl. Sex Determination)
- Epigenetics (incl. Genome Methylation and Epigenomics)
- Biomarkers
- Genomics
- Genome Structure and Regulation
- Genetic Engineering
CC BY 4.0